Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021

Fig. 1

(A) Proportion of HIV-1 transmitted drug resistance (TDR) mutations to PIs, NRTIs, and NNRTIs. (B) Levels of HIV-1 TDR associated mutations to different ART drug among 1006 newly diagnosed HIV/AIDS patients. PI, Protease inhibitor;NRTI, Nucleoside reverse transcriptase inhibitor; NNRTI, Non-nucleoside reverse transcriptase inhibitor; NFV: Nelfinavir;ABC: Abacavir; AZT: Zidovudine; D4T: Stavudine; DDI: Didanosine; FTC: Emtricitabine;3TC, Lamivudine;TDF, Tenofovir; DOR,Doravirine; EFV,Efavirenz; ETR: Etravirine; RPV: Rilpivirine

Back to article page

Virology Journal

ISSN: 1743-422X